We Need to Rethink Our Treatment of Pain
Cutting off access to pain medication will only hurt people who are truly suffering.
As Chain Pharmacies Close, Mom-and-Pops Pick Up the Slack
Some small independent pharmacies in the city are benefiting from a decline in chain stores. But theft and low reimbursement rates are still making life hard.
Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion
The deal is a bet on the growing market for psychiatric and neurological drugs.
Fake Ozempic Found in U.S., F.D.A. Warns
The agency and Novo Nordisk, the company that makes Ozempic, are testing the seized medications to determine what is in them.
What to Know About Antibiotics and Antimicrobial Resistance
It’s antibiotic season. Brush up on how you should use them — and when to avoid them.
Can Ozempic and Weight Loss Drugs Treat Other Diseases?
Scientists are exploring whether the new diabetes and weight-loss drugs could also treat addiction, kidney disease and more.
We Know How to Put People on Ozempic. Do We Know How to Get Them Off It?
How informed consent about long-term prescriptions can be improved.
Behind the Shortage Keeping Cancer Patients From Chemo
Key drugs have been in scarce supply, revealing a deep crisis in the generic drug industry.
New Hope — and an Old Hurdle — for a Terrible Disease With Terrible Treatments
Researchers in developing countries are trying to find treatments for conditions that affect the poorest people. But the system is stacked against their therapies.
Possible Ways to Ease Drug Shortages
Lawmakers, U.S. officials and industry experts have offered measures to try to shore up the generic drug market.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.